Archives

by in
Entry Author Date Location
Histogenics Brings In $49M for Tissue Regeneration—and Recapitalization 07/24/12 Boston
Histogenics Obtains $49,000,000 Series A Funding 07/24/12 Boston
Histogenics Receives $49,000,000 Series A Round 07/24/12 Boston
San Diego Life Sciences Roundup: Halozyme, Sophiris, Arena, & More 07/12/12 San Diego
Sophiris Moves to Unlock Blockbuster Potential in New Prostate Drug 07/10/12 San Diego
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
CrestaTech Receives $13,000,000 New Funding Round 05/01/12 San Francisco
Biotech Can’t Sidestep Cost-Effectiveness Anymore 04/02/12 National
In Life Sciences Partnerships, You Must be Smart from the Beginning 01/20/12 San Diego
Cebix to Raise $20 Million for Pivotal Trial of Diabetes Supplement 01/10/12 San Diego
Biotech VCs Have a Problem, and it Will Get Worse Before It Gets Better 10/24/11 National
Khosla, Sunpreme, Grockit: Bay Area BizTech News by the Numbers 10/17/11 San Francisco
Sofinnova Ventures Defies the Grim Mood, Raises $440M For Biotech-Only VC Fund 10/17/11 San Francisco
SARCode Secures $44,000,000 Series B Round 07/18/11 San Francisco
Sorbent Therapeutics Seeks to Fight Heart Failure in Unusual Arena: The Gut 07/13/11 San Francisco
SpineVision Obtains $5,000,000 New Financing 07/06/11 San Francisco
Sorbent Therapeutics Absorbs $36M to Go After New Treatment For Kidney, Heart Failure 06/30/11 San Francisco
Sorbent Therapeutics Obtains $36,000,000 Series B Financing Round 06/30/11 San Francisco
BioAmber Secures $45,000,000 Series B Financing 05/04/11 Detroit
See You Tonight at “San Diego’s Fight Against Diabesity” 01/27/11 San Diego
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News 01/20/11 San Diego
NextWave Pharma Snaps Up $45M 01/11/11 San Francisco
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27 12/27/10 San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive? 12/03/10 San Diego
Anthera, On a Lean Budget, Seeks to Tap Big Heart Attack Market By Blocking Inflammation 11/16/10 San Francisco
Hyperion Hits Goal in Trial for Rare-Disease Drug, Prepping FDA Application 11/03/10 San Francisco
Phenomix, Former Highflying Diabetes Drugmaker, Shuts Down After Forest Labs Walks 10/26/10 San Diego
Sorbent Therapeutics Secures $21,800,000 Series B Funding 09/13/10 Detroit
KXEN Garners $8,000,000 Series D Financing 06/16/10 San Francisco
Avalon Stakes Claim as Survivor Among San Diego Biotech VCs 04/12/10 San Diego
Page 2 of 4 « previous page · next page »